In the first pathway, in early-stage CRC, the upregulated CASC2 transmits the signal to HINFP, which is modified by ubiquitination to inhibit tumor growth (Baldinu et al., 2007), and transmits the signal to TF TCF3 through SMG8. Here, SMG8 is linked to neoplasm.